Recently our group identified elevated C9 in the serum and tumors of patients with esophageal adenocarcinoma (EAC) (6, 7), a cancer of the gastro-esophageal junction associated with chronic gastro-esophageal reflux (GERD) (8–10). This evidence concerns the gene C9 and gastroesophageal reflux disease.